GIVEN the wide range of inhaler devices available, patients with chronic obstructive pulmonary disease (COPD) need their inhaler technique and adherence checked regularly, according to new 'COPD-X Australian & NZ guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update'.
Published by Lung Foundation Australia in conjunction with the Thoracic Society, the new guidelines place the pharmacist in a "critical" role supporting COPD patients.
Other key elements highlighted in COPD management included smoking cessation, education, and a strong partnership between primary and tertiary care, to facilitate evidence-based management of patients' health.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Nov 17
